세계의 뇌경색 치료 시장 보고서(2025년)

Cerebral Infarction Treatment Global Market Report 2025

US $ 4,490 ￦ 6,222,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,993,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,765,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

뇌경색 치료제 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 7.0%의 연평균 성장률(CAGR)을 기록하며 155억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 노인 인구의 확대, 뇌졸중 유병률 증가, 뇌혈관 질환 및 심혈관질환의 증가, 뇌경색 발생률의 증가에 기인하는 것으로 보입니다. 이 기간 동안 예상되는 주요 동향으로는 원격의료의 통합, 웨어러블 건강 모니터링 기기의 사용, 신경 영상 기술의 발전, 로봇 보조 수술의 채택, 나노기술을 통한 약물전달 시스템, 가상 재활 플랫폼의 개발 등이 있습니다.

뇌졸중 유병률의 증가는 향후 몇 년 동안 뇌졸중 치료제 시장의 성장을 촉진할 것으로 예상됩니다. 뇌졸중은 뇌로 가는 혈류가 끊어지거나 차단되어 뇌 조직에 산소와 영양분이 부족해지면서 발생합니다. 뇌졸중 환자의 증가는 혈관을 손상시켜 뇌졸중 위험의 원인이 되는 고혈압의 증가에 기인하는 바가 큽니다. 뇌경색 치료는 뇌혈류를 회복시키고 장기적인 손상과 장애를 최소화함으로써 뇌졸중 치료에 중요한 역할을 합니다. 이러한 치료는 적시에 의료적 개입을 통해 환자의 예후를 개선하고 보다 효과적이고 관리하기 쉬운 회복을 가져옵니다. 예를 들어, 2024년 9월 호주에 본부를 둔 비영리 단체인 뇌졸중 재단은 2023년 호주에서 4,5,785명의 뇌졸중 환자가 발생하여 2050년에는 7만 2,000명까지 크게 증가할 것으로 예측했습니다. 이처럼 뇌졸중 유병률의 증가는 뇌졸중 치료 시장의 확대를 촉진하는 중요한 요인이 되고 있습니다.

뇌졸중 치료 시장의 주요 기업들은 급성 허혈성 뇌졸중 환자의 치료 시간을 단축하기 위해 이중 흡입 기술과 같은 첨단 기술 개발을 우선시하고 있습니다. 이중 흡입 기술은 뇌졸중 중재시 혈전제거 효율을 향상시키기 위해 두 개의 카테터를 동시에 사용하는 기술입니다. 예를 들어, 2025년 5월 미국의 의료 기술 기업 Imperative Care는 최첨단 뇌졸중 치료 기기인 Zoom DuoPort를 발표했습니다. 이 시스템은 하나의 진공 소스로 두 개의 카테터를 동시에 작동시켜 이중 흡입을 지원합니다. 이 시스템은 의사의 제어를 강화하고 실시간 시술 피드백을 제공하여 급성 허혈성 뇌졸중 치료에서 기계적 혈전제거술의 효과를 높입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 뇌경색 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 뇌경색 치료 시장 : 성장률 분석
• 세계의 뇌경색 치료 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 뇌경색 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 뇌경색 치료 : 총 잠재 시장 규모(TAM)

제6장 시장 세분화

• 세계의 뇌경색 치료 시장 : 치료 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 의약품
• 외과적 개입
• 재활 요법
• 세계의 뇌경색 치료 시장 : 진단 툴별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 컴퓨터 단층촬영 스캔
• 자기공명영상법
• 혈관조영 검사
• 도플러 초음파
• 세계의 뇌경색 치료 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 허혈성 뇌졸중
• 일과성 뇌허혈발작
• 대동맥성 뇌졸중
• 소혈관성 뇌졸중
• 세계의 뇌경색 치료 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원
• 전문 뇌졸중 센터
• 외래 수술 센터
• 재택 간병 서비스 제공자
• 세계의 뇌경색 치료 시장, 의약품 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 항혈소판제
• 항응고제
• 혈전용해제
• 스타틴
• 항고혈압제
• 세계의 뇌경색 치료 시장, 외과적 개입 하위 세분화, 유형, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 기계적 혈전제거술
• 경동맥내막절제술
• 감압 개두술
• 스텐트 유치
• 혈관성형술
• 세계의 뇌경색 치료 시장, 재활 요법 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 물리치료
• 작업치료
• 언어치료
• 인지 재활
• 심리 상담

제7장 지역별·국가별 분석

• 세계의 뇌경색 치료 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 뇌경색 치료 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 뇌경색 치료 시장 : 경쟁 구도
• 뇌경색 치료 시장 : 기업 개요
  • Pfizer Inc.
  • Johnson & Johnson
  • F. Hoffmann-La Roche AG
  • Bayer AG
  • Sanofi S.A.

제31장 기타 주요 기업과 혁신적 기업

• AstraZeneca plc
• Abbott Laboratories
• Novartis AG
• Medtronic plc
• Amgen Inc.
• Siemens Healthineers
• Becton, Dickinson and Company
• Stryker Corporation
• Boston Scientific Corporation
• Daiichi Sankyo Company Limited
• Penumbra Inc.
• Terumo Corporation
• phenox GmbH
• Boehringer Ingelheim International GmbH
• Imperative Care Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

• 뇌경색 치료 시장, 2029년 : 새로운 기회를 제공하는 국가
• 뇌경색 치료 시장, 2029년 : 새로운 기회를 제공하는 부문
• 뇌경색 치료 시장, 2029년 : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Cerebral infarction treatment involves medical interventions designed to restore blood flow to the brain and limit the damage caused by a stroke resulting from blocked blood vessels (ischemic stroke). The primary goal of this treatment is to prevent additional brain injury, reduce neurological impairments, and enhance patient recovery.

The core types of treatment for cerebral infarction include medications, surgical procedures, and rehabilitation therapies. Medications used in this context aim to dissolve blood clots, regulate blood pressure, and prevent future strokes. Diagnostic methods employed in treatment consist of computed tomography (CT) scans, magnetic resonance imaging (MRI), angiography, and Doppler ultrasound. The treatment is applied to conditions such as ischemic stroke, transient ischemic attack, large artery stroke, and small vessel stroke, with end-users including hospitals, dedicated stroke centers, ambulatory surgical centers, and home care services.

The cerebral infarction treatment market research report is one of a series of new reports from The Business Research Company that provides cerebral infarction treatment market statistics, including cerebral infarction treatment industry global market size, regional shares, competitors with a cerebral infarction treatment market share, detailed cerebral infarction treatment market segments, market trends and opportunities, and any further data you may need to thrive in the cerebral infarction treatment industry. This cerebral infarction treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cerebral infarction treatment market size has grown strongly in recent years. It will grow from $11.05 billion in 2024 to $11.84 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to higher healthcare expenditure, an increase in hospital admissions, a rise in minimally invasive stroke procedures, growing demand for mechanical thrombectomy devices, and an expansion in clinical trials.

The cerebral infarction treatment market size is expected to see strong growth in the next few years. It will grow to $15.54 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The projected growth in the forecast period can be attributed to the expanding geriatric population, a rising prevalence of stroke, an increase in cerebrovascular and cardiovascular diseases, and a growing incidence of cerebral infarction. Key trends expected during this period include the integration of telemedicine, the use of wearable health monitoring devices, advancements in neuroimaging techniques, the adoption of robotic-assisted surgery, nanotechnology-based drug delivery systems, and the development of virtual rehabilitation platforms.

The rising prevalence of stroke is anticipated to drive the growth of the cerebral infarction treatment market in the coming years. A stroke occurs when blood flow to the brain is disrupted or blocked, leading to a deficiency of oxygen and nutrients in brain tissue. This increase in stroke cases is largely attributed to the growing incidence of hypertension, which damages blood vessels and contributes to stroke risk. Cerebral infarction treatments play a crucial role in stroke care by restoring cerebral blood flow, minimizing long-term damage and disability. These treatments enhance patient outcomes through timely medical intervention, resulting in more effective and manageable recovery. For example, in September 2024, the Stroke Foundation, an Australia-based not-for-profit organization, reported that Australia experienced 45,785 stroke cases in 2023, with projections indicating a significant increase to 72,000 cases by 2050. Thus, the growing prevalence of stroke is a key factor fueling the expansion of the cerebral infarction treatment market.

Leading companies in the cerebral infarction treatment market are prioritizing the development of advanced technologies, such as dual aspiration technology, to reduce treatment time for patients with acute ischemic stroke. Dual aspiration technology involves the simultaneous use of two catheters to improve the efficiency of clot removal during stroke interventions. For example, in May 2025, Imperative Care, a U.S.-based medical technology company, introduced Zoom DuoPort, a cutting-edge stroke treatment device. This system supports dual aspiration by allowing two catheters to function concurrently with a single vacuum source. It enhances physician control, offers real-time procedural feedback, and increases the effectiveness of mechanical thrombectomy in treating acute ischemic stroke.

In March 2025, Medtronic plc, an Ireland-based medical device company, formed a partnership with Methinks AI to incorporate AI-powered stroke detection software into its neurovascular care solutions. The collaboration is intended to improve early stroke diagnosis, optimize triage processes, and enhance treatment outcomes, particularly in underserved areas. Methinks AI, a digital health company based in Spain, specializes in developing artificial intelligence solutions for the diagnosis and management of stroke.

Major players in the cerebral infarction treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers, Becton, Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Daiichi Sankyo Company Limited, Penumbra Inc., Terumo Corporation, phenox GmbH, Boehringer Ingelheim International GmbH, Imperative Care Inc., Acandis GmbH & Co. KG, Reflow Medical Inc., Lumosa Therapeutics Inc., Insera Therapeutics Inc., Q'Apel Medical Inc.

North America was the largest region in the cerebral infarction treatment market in 2024. The regions covered in cerebral infarction treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cerebral infarction treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cerebral infarction treatment market consists of revenues earned by entities by providing services such as thrombolytic therapy administration, surgical interventions, rehabilitation programs, diagnostic imaging, and post-treatment patient care and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The cerebral infarction treatment market also includes sales of anticoagulants, antiplatelet agents, thrombolytics, neuroprotective drugs, as well as medical devices such as stents, catheters, and diagnostic imaging equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cerebral Infarction Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cerebral infarction treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cerebral infarction treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cerebral infarction treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Medication; Surgical Interventions; Rehabilitation Therapies
• 2) By Diagnostic Tools: Computed Tomography Scan; Magnetic Resonance Imaging; Angiography; Doppler Ultrasound
• 3) By Application: Ischemic Stroke; Transient Ischemic Attack; Large Artery Stroke; Small Vessel Stroke
• 4) By End-User: Hospitals; Specialized Stroke Centers; Ambulatory Surgical Centers; Home Care Providers
• Subsegments:
• 1) By Medication: Antiplatelet Drugs; Anticoagulants; Thrombolytics; Statins; Antihypertensives
• 2) By Surgical Interventions: Mechanical Thrombectomy; Carotid Endarterectomy; Decompressive Craniectomy; Stent Placement; Angioplasty
• 3) By Rehabilitation: Physical Therapy; Occupational Therapy; Speech and Language Therapy; Cognitive Rehabilitation; Psychological Counseling
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Bayer AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cerebral Infarction Treatment Market Characteristics

3. Cerebral Infarction Treatment Market Trends And Strategies

4. Cerebral Infarction Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cerebral Infarction Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cerebral Infarction Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cerebral Infarction Treatment Market Growth Rate Analysis
• 5.4. Global Cerebral Infarction Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cerebral Infarction Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cerebral Infarction Treatment Total Addressable Market (TAM)

6. Cerebral Infarction Treatment Market Segmentation

• 6.1. Global Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Surgical Interventions
• Rehabilitation Therapies
• 6.2. Global Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Computed Tomography Scan
• Magnetic Resonance Imaging
• Angiography
• Doppler Ultrasound
• 6.3. Global Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ischemic Stroke
• Transient Ischemic Attack
• Large Artery Stroke
• Small Vessel Stroke
• 6.4. Global Cerebral Infarction Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialized Stroke Centers
• Ambulatory Surgical Centers
• Home Care Providers
• 6.5. Global Cerebral Infarction Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiplatelet Drugs
• Anticoagulants
• Thrombolytics
• Statins
• Antihypertensives
• 6.6. Global Cerebral Infarction Treatment Market, Sub-Segmentation Of Surgical Interventions, Of Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mechanical Thrombectomy
• Carotid Endarterectomy
• Decompressive Craniectomy
• Stent Placement
• Angioplasty
• 6.7. Global Cerebral Infarction Treatment Market, Sub-Segmentation Of Rehabilitation Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Therapy
• Occupational Therapy
• Speech and Language Therapy
• Cognitive Rehabilitation
• Psychological Counseling

7. Cerebral Infarction Treatment Market Regional And Country Analysis

• 7.1. Global Cerebral Infarction Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cerebral Infarction Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cerebral Infarction Treatment Market

• 8.1. Asia-Pacific Cerebral Infarction Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cerebral Infarction Treatment Market

• 9.1. China Cerebral Infarction Treatment Market Overview
• 9.2. China Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cerebral Infarction Treatment Market

• 10.1. India Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cerebral Infarction Treatment Market

• 11.1. Japan Cerebral Infarction Treatment Market Overview
• 11.2. Japan Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cerebral Infarction Treatment Market

• 12.1. Australia Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cerebral Infarction Treatment Market

• 13.1. Indonesia Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cerebral Infarction Treatment Market

• 14.1. South Korea Cerebral Infarction Treatment Market Overview
• 14.2. South Korea Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cerebral Infarction Treatment Market

• 15.1. Western Europe Cerebral Infarction Treatment Market Overview
• 15.2. Western Europe Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cerebral Infarction Treatment Market

• 16.1. UK Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cerebral Infarction Treatment Market

• 17.1. Germany Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cerebral Infarction Treatment Market

• 18.1. France Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cerebral Infarction Treatment Market

• 19.1. Italy Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cerebral Infarction Treatment Market

• 20.1. Spain Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cerebral Infarction Treatment Market

• 21.1. Eastern Europe Cerebral Infarction Treatment Market Overview
• 21.2. Eastern Europe Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cerebral Infarction Treatment Market

• 22.1. Russia Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cerebral Infarction Treatment Market

• 23.1. North America Cerebral Infarction Treatment Market Overview
• 23.2. North America Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cerebral Infarction Treatment Market

• 24.1. USA Cerebral Infarction Treatment Market Overview
• 24.2. USA Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cerebral Infarction Treatment Market

• 25.1. Canada Cerebral Infarction Treatment Market Overview
• 25.2. Canada Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cerebral Infarction Treatment Market

• 26.1. South America Cerebral Infarction Treatment Market Overview
• 26.2. South America Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cerebral Infarction Treatment Market

• 27.1. Brazil Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cerebral Infarction Treatment Market

• 28.1. Middle East Cerebral Infarction Treatment Market Overview
• 28.2. Middle East Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cerebral Infarction Treatment Market

• 29.1. Africa Cerebral Infarction Treatment Market Overview
• 29.2. Africa Cerebral Infarction Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cerebral Infarction Treatment Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cerebral Infarction Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cerebral Infarction Treatment Market Competitive Landscape And Company Profiles

• 30.1. Cerebral Infarction Treatment Market Competitive Landscape
• 30.2. Cerebral Infarction Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Cerebral Infarction Treatment Market Other Major And Innovative Companies

• 31.1. AstraZeneca plc
• 31.2. Abbott Laboratories
• 31.3. Novartis AG
• 31.4. Medtronic plc
• 31.5. Amgen Inc.
• 31.6. Siemens Healthineers
• 31.7. Becton, Dickinson and Company
• 31.8. Stryker Corporation
• 31.9. Boston Scientific Corporation
• 31.10. Daiichi Sankyo Company Limited
• 31.11. Penumbra Inc.
• 31.12. Terumo Corporation
• 31.13. phenox GmbH
• 31.14. Boehringer Ingelheim International GmbH
• 31.15. Imperative Care Inc.

32. Global Cerebral Infarction Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cerebral Infarction Treatment Market

34. Recent Developments In The Cerebral Infarction Treatment Market

35. Cerebral Infarction Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Cerebral Infarction Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cerebral Infarction Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cerebral Infarction Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료